Nativis Voyager for Newly Diagnosed GBM

Clinical trial NCT03276286 · COMPLETED

Trial details

NCT number: NCT03276286
Sponsor: Nativis, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2017-11-10
Primary completion: 2022-05-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.